Donor‐Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants

For patients with chronic renal and liver diseases, simultaneous liver and kidney transplantation (SLKT) is the best therapeutic option. The role of a pretransplant donor‐specific antibody (DSA) in SLKT is unclear. We report the results of a retrospective review from 7/08 to 10/09 of SLKT at our ins...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of transplantation 2011-04, Vol.11 (4), p.841-847
Hauptverfasser:	Dar, W., Agarwal, A., Watkins, C., Gebel, H. M., Bray, R. A., Kokko, K. E., Pearson, T. C., Knechtle, S. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibody Specificity Antibody‐mediated rejection Biological and medical sciences Genes, MHC Class I - immunology Genes, MHC Class II - immunology Graft Rejection - immunology Graft Survival Histocompatibility Testing Humans Isoantibodies - immunology kidney allograft Kidney Transplantation - immunology liver allograft Liver Transplantation - immunology Medical sciences Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue Donors Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!